Andrea Antinori to Longitudinal Studies
This is a "connection" page, showing publications Andrea Antinori has written about Longitudinal Studies.
Connection Strength
0.096
-
Clinical Presentation and Outcomes of Severe Acute Respiratory Syndrome Coronavirus 2-Related Encephalitis: The ENCOVID Multicenter Study. J Infect Dis. 2021 01 04; 223(1):28-37.
Score: 0.036
-
COVID-19 disease-Temporal analyses of complete blood count parameters over course of illness, and relationship to patient demographics and management outcomes in survivors and non-survivors: A longitudinal descriptive cohort study. PLoS One. 2020; 15(12):e0244129.
Score: 0.018
-
Peripheral blood HIV-1 DNA dynamics in antiretroviral-treated HIV/HCV co-infected patients receiving directly-acting antivirals. PLoS One. 2017; 12(10):e0187095.
Score: 0.014
-
Mild Cognitive Impairment and Progression to Dementia in Progressive Supranuclear Palsy. Neurodegener Dis. 2017; 17(6):286-291.
Score: 0.014
-
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study. Lancet Gastroenterol Hepatol. 2017 06; 2(6):427-434.
Score: 0.014